Sight Sciences saw the highest growth of 19% in patent filings in October and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 19% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Sight Sciences’s patent filings and grants. Buy the databook here.
Sight Sciences has been focused on protecting inventions in Australia(AU) with one publication in Q4 2023
The Australia(AU) Patent Office dominates the patent filings and grants with nearly . The World Intellectual Property Organization(WIPO), Australia(AU), and Canada(CA) patent Office are among the top ten patent offices where Sight Sciences is filings its patents. Among the top granted patent authorities, Sight Sciences has 50% of its grants in Australia(AU) and 50% in Canada(CA).
F. Hoffmann-La Roche and Alcon could be the strongest competitors for Sight Sciences
See Also:
In terms of grant share, Sight Sciences stands in tenth position among its competitors. F. Hoffmann-La Roche and Alcon secured the top positions according to recent patent publication data.
Ophthalmic devices related patents lead Sight Sciences portfolio followed by general surgery devices
Sight Sciences has highest number of patents in ophthalmic devices followed by general surgery devices. For ophthalmic devices, nearly 50% of patents were filed and 100% of patents were granted in Q4 2023.
For comprehensive analysis of Sight Sciences's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.